Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Environmental factors and their regulation of immunity in multiple sclerosis.
Teriflunomide for oral therapy in multiple sclerosis.
Role of SFB in autoimmune arthritis: An example of regulation of autoreactive T cell sensitivity in the gut.
Progress of mesenchymal stem cell therapy for neural and retinal diseases.
Diagnostic value of 3D fluid attenuated inversion recovery sequence in multiple sclerosis.
Cell fusion in the brain: two cells forward, one cell back.
Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis.
Therapeutic strategies of urinary disorders in MS. Practice and algorithms.
Mesenchymal Stem Cell-Based Therapy in a Mouse Model of Experimental Autoimmune Encephalomyelitis (EAE).
Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration.
Selective inhibition by riluzole of voltage-dependent sodium channels and catecholamine secretion in adrenal chromaffin cells.
Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
FDA Drug Safety Communication: FDA investigating rare brain infection in patient taking Gilenya (fingolimod)
Impact of delayed diagnosis and treatment in clinically isolated syndrome and multiple sclerosis.
Poster abstracts from the third international symposium on gait and balance in multiple sclerosis: selecting the right measures.
Multiple sclerosis: Study in MS reveals impairments in 'theory of mind'
Imaging of glutamate in the spinal cord using GluCEST.
Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies.
Assessing spinal cord function in multiple sclerosis with functional neuroimaging: insights and limitations.
Imaging Cortical Damage and Dysfunction in Multiple Sclerosis.
Positive Effect on Multiple Sclerosis With Treatment of Metabolic Syndrome.
Dalfampridine in hereditary spastic paraplegia: a prospective, open study.
Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin d supplementation is a red herring.
Spinocerebellar Ataxias Type 8, 12, and 17 and Dentatorubro-Pallidoluysian Atrophy in Czech Ataxic Patients.
Pages
« first
‹ previous
…
302
303
304
305
306
307
308
309
310
…
next ›
last »